Gastroenterology and Hepatology - Issue 1/2022
30
35
Point-of-care method for measuring infliximab and adalimumab trough levels in inflammatory bowel disease patients on biologic therapy
Kaštylová K., Černá K., Luxová Š., Šebek P., Lukáš M.
46
Safety of vedolizumab and ustekinumab in the treatment of pregnant women with inflammatory bowel disease – a multicentre retrospective-prospective observational study
Pipek- B., Ďuricová D., Mitrová K., Bortlík M., Bouchner L., Březina J., Douda T., Drašar T., Drastich P., Falt P., Klvaňa P., Kohout P., Leksa V., Novotný A., Svoboda P., Škorpík J., Ulbrych J., Veinfurt M., Zbořilová B., Lukáš M.
Clinical and Experimental Gastroenterology: Review Article
60
The importance of home parenteral nutrition in clinical practice – own experience from our workplace
Fojtová A., Norek B., Gazdíková K.
67
Desmoid fibromatosis – a rare mesenteric tumor
Grochol L., Cibulková I., Hrudka J., Hajer J.
Gastroenterology and Hepatology
2022 Issue 1
Most read in this issue
- Desmoid fibromatosis – a rare mesenteric tumor
- The importance of home parenteral nutrition in clinical practice – own experience from our workplace
- Safety of vedolizumab and ustekinumab in the treatment of pregnant women with inflammatory bowel disease – a multicentre retrospective-prospective observational study
- Biosimilar treatment in paediatric gastroenterology – current view